Altogether, metabolomic data suggest that a decreased GPChol/PChol ratio isassociated with high-grade tumors and that the expression of HDAC1,HDAC4 and SIRT1 may influence tumor aggressiveness throughchanges in metabolomic profiles of tumors. This evidence concerns the gene HDAC1 and neoplasm.